Tahmasbi Bahram, Abedi Ghasem, Moosazadeh Mahmood, Janbabai Ghasem, Farshidi Fereshteh, Mansori Kamyar, Moradi Yousef, Khosravi Shadmani Fatemeh, Parang Serveh, Khazaei Zaher
Health Sciences Research Center, Departman of Public Health, Mazandaran University of Medical Sciences, Sari, Iran. Email:
Asian Pac J Cancer Prev. 2018 Nov 28;19(11):3009-3018. doi: 10.31557/APJCP.2018.19.11.3009.
Objective: Colorectal cancer is one of the most common causes of death in the world. Despite of remarkable advances in medical sciences, cancer is an important disease and the second cause of death after cardiovascular diseases. The present study was aimed at determining the survival rate of colorectal cancer in Iran. Methods: The present study is a systematic review of national and international electronic databases. Studies that had the inclusion criteria were included in the study, electronically published articles over December 2007 and March 2015 were retrieved. The collected data were analyzed by meta-analytic method through stata 11.0 Software, and the survival rate was measured. Results: The 1-, 2-, 3-, 4-, and 5-year survival rates of colorectal cancer in Iran were respectively calculated as 85, 75.10, 65, 55.40, and 52.The results indicated that there is a significant relationship between anatomic location of tumor and survival rate. According to the results of this examination, survival rate of the patients with rectal cancer was 41.9 times higher than those with colorectal cancer. Conclusion: Due to the relative high prevalence of this cancer among young people in Iran and the low survival rate, early diagnosis of colorectal neoplasms is necessary before they become symptomatic through more effective diagnosis programs of enhancing the patients’ health and survival rate. Moreover, it is necessary to conduct more specialized and relevant studies in order to determine genetic or environmental causes of cancer such as diet and cultural and behavioral habits at the national level and with different ethnicities.
目的:结直肠癌是全球最常见的死因之一。尽管医学科学取得了显著进展,但癌症仍是一种重要疾病,是仅次于心血管疾病的第二大死因。本研究旨在确定伊朗结直肠癌的生存率。方法:本研究是对国家和国际电子数据库的系统综述。纳入符合纳入标准的研究,检索2007年12月至2015年3月间电子发表的文章。通过stata 11.0软件采用荟萃分析方法对收集的数据进行分析,并测量生存率。结果:伊朗结直肠癌的1年、2年、3年、4年和5年生存率分别计算为85%、75.10%、65%、55.40%和52%。结果表明肿瘤的解剖位置与生存率之间存在显著关系。根据本次检查结果,直肠癌患者的生存率比结肠癌患者高41.9倍。结论:由于这种癌症在伊朗年轻人中相对高发且生存率较低,通过更有效的诊断项目在结直肠肿瘤出现症状之前进行早期诊断对于提高患者健康水平和生存率很有必要。此外,有必要开展更专业和相关的研究,以确定在国家层面以及不同种族中癌症的遗传或环境原因,如饮食以及文化和行为习惯。
Asian Pac J Cancer Prev. 2018-11-28
Asian Pac J Cancer Prev. 2019-1-25
Asian Pac J Cancer Prev. 2009
Dan Med J. 2012-4
Epidemiol Prev. 2016
Asian Pac J Cancer Prev. 2016
J Gastrointest Cancer. 2020-6
J Health Popul Nutr. 2024-7-31
Gastroenterol Hepatol Bed Bench. 2022
Epidemiol Health. 2017-5-17
Asian Pac J Cancer Prev. 2016
Asian Pac J Cancer Prev. 2014
Addict Health. 2013
Int J Prev Med. 2013-10
J Surg Oncol. 2013-12-7
Asian Pac J Cancer Prev. 2013
J Egypt Natl Canc Inst. 2013-9